Samsung's Galaxy S25 will exclusively feature Snapdragon 8 Gen 4 worldwide, while the upcoming Fold7 and Flip7 foldables are set to utilize the Exynos 2500 chip, a new rumor from Korea reveals.
Snapdragon 8 Gen 4 Exclusively in Galaxy S25 Worldwide
A great deal of back and forth has taken place over the course of the past several months concerning the chipset(s) that will be used to power Samsung's forthcoming Galaxy S25 series, which is anticipated to be released in January at the very least.
In the beginning, GSM Arena was informed that it would be an exclusive event for Exynos, but then two different reports informed us that Snapdragon would be present everywhere.
Latest Rumor Confirms Snapdragon for Galaxy S25
Now, another rumor, this time coming from Samsung's own country of Korea (via Hankyung), proves that the Snapdragon has won.
According to reports, the Galaxy S25, Galaxy S25+, and Galaxy S25 Ultra will all feature Qualcomm's Snapdragon 8 Gen 4 in their respective global versions. It would appear that this practice was carried out in order to "maximize the performance" of the S25 series.
Exynos 2500 Reserved for Samsung's Fold 7 and Flip 7
Instead, the Exynos 2500 will be utilized in the Galaxy Z Fold7 and Galaxy Z Flip7, both of which are scheduled to be commercially available in the latter half of the following year. Given that the foldables have, up until this point, relied on Snapdragon CPUs, this is an intriguing turn of events.
In relation to the source, Samsung will have the opportunity to bolster the 2500's performance and increase its yield until they are released.


Google Expands AI Partnership With Singapore Government
Samsung Faces Major Strike Threat as Union Restarts Pay Talks
GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism
X Corp Loses Legal Battle Over Australia Child Safety Fine
Mistral AI Acquires Emmi AI to Expand Industrial AI Solutions in Europe
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Samsung Shares Surge After Strike Deal Eases Labor Tensions
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
Texas Sues Meta Over WhatsApp Encryption Claims
OpenAI Expands Globally with First Overseas AI Lab in Singapore
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
China vs U.S. AI Race Shifts Toward Robotics and Manufacturing Power in 2026 



